The Leona M. and Harry B. Helmsley Charitable Trust aspires to improve lives by supporting exceptional efforts in the U.S. and around the world in health and select place-based initiatives. The mission of Vivli aligns directly with this goal.
“Every day, we are reminded of the urgent need to accelerate medical research. Too many people around the world are suffering from disease and need more effective treatments,” said Stephanie Cuskley, CEO of the Helmsley Charitable Trust, a founding member of Vivli. “Partners like Vivli offer a unique opportunity for research institutions to maximize their impact by sharing data and working together to propel new scientific discoveries forward.”
Dr. Gina Agiostratidou, Program Director for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program, which aims to advance research, treatments, technologies, and services that improve the life of people with type 1 diabetes, participated as a panelist at the Vivli Platform launch event in July of 2018, demonstrating her organization’s commitment to furthering the reach and benefit of data sharing.
Dr. Gina Agiostratidou, Helmsley Charitable Trust, at the Vivli Launch Event.